ATTBF Financials 07/15/2014 20:03:26 Abattis Bioc

ATTBF Financials 07/15/2014 20:03:26
Abattis Bioceuticals Corp.
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011 Oct 01, 2010
Total Revenue 17 - - -
Cost of Revenue 11 - - -
Gross Profit 5 - - -
Operating Expenses
Research and Development 120 126 407 -
Sales, General and Admin. 640 692 1,057 -
Non-Recurring Items 163 167 50 -
Other 85 45 31 -
Operating Income (1,003) (1,031) (1,546) -
Income From Continuing Operations
Add'l Income/Expense Items (57) 25 185 -
Earnings Before Interest and Tax (1,060) (1,006) (1,361) -
Interest Expense 12 3 - -
Earnings Before Tax (1,073) (1,009) (1,361) -
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,073) (1,009) (1,361) -
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,073) (1,009) (1,361) -
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,073) (1,009) (1,361) -